Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Metabolism Prediction Model in Liver Transplant
NCT02752529Unknown
- Sponsor
- Shanghai General Hospital
- Start
- Mar 2016
- Primary completion
- Dec 2019
- Countries
- 1
01
Overview
Open-label trial of tacrolimus in graft rejection, sponsored by Shanghai General Hospital. Primary endpoint: Area under the plasma concentration versus time curve at 7 days. Status: unknown.
02
Drugs
tacrolimus
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT02752529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02752529.